Download Citation
Article Source:
Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
Uwagawa T,
Sakamoto T,
Gocho T,
Shiba H,
Onda S,
et al.
(2022)
Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
PLOS ONE 17(5): e0267623.
https://doi.org/10.1371/journal.pone.0267623